Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
447,472
-
Share change
-
+447,472
-
Total reported value
-
$5,281,000
-
Price per share
-
$11.81
-
Number of holders
-
11
-
Value change
-
+$5,281,007
-
Number of buys
-
11
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q1 2022
As of 31 Mar 2022,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
447,472 shares.
The largest 10 holders included
FMR LLC, BARCLAYS PLC, CAPSTONE INVESTMENT ADVISORS, LLC, CITADEL ADVISORS LLC, Ergoteles LLC, MORGAN STANLEY, Penserra Capital Management LLC, Tower Research Capital LLC (TRC), CLEAR STREET LLC, and UBS Group AG.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.